Clinical Trials Browser

Sulindac × Head & Neck × Clear all

NCT01515137 2023-03-28

Study of TARCEVA (Erlotinib) as Adjuvant Treatment for Locally Advanced Head and Neck Squamous Cell Carcinoma

Phase 1 Completed

Squamous Cell Carcinoma of Head and Neck

NCT00299195 2020-11-19

A Randomized Study of Sulindac in Oral Premalignant Lesions

Phase NA Completed

63 enrolled 10 charts

Coproporphyria, Leukoplakia, Oral, Neoplasms

NCT00392665 2017-04-13

Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck

Phase 2 Terminated

36 enrolled 10 charts

Squamous Cell Carcinoma of Head and Neck